Reading the Johnson & Johnson Earnings Tea Leaves

By Brenton Flynn – Jan 22, 2013 at 2:58PM

NYSE: JNJ

Johnson & Johnson

Market Cap

$354B

Today's Change

(-1.15%) -$1.71

Current Price

$146.82

Price as of April 25, 2024, 4:00 p.m. ET

J&J's earnings call presented a number of derivative investing insights

With another earnings season upon us, the Fool's health-care team is busy making sure investors know what to expect from their favorite companies this quarter, while also maintaining a focus on the long term.

In the following video, health-care bureau chief Brenton Flynn outlines some derivative insights from today's Johnson & Johnson (JNJ -1.15%) earnings call, where he made a number of observations and found implications for Medivation (MDVN), Zimmer (NYSE: ZMH), Stryker (SYK 0.09%), and potentially Abbott Labs (ABT -0.03%).

Brenton Flynn has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson and Zimmer Holdings. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.